PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling
Oncotarget · 2025
DOI: 10.18632/oncotarget.28720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, 2025. Verfasst von Reem Ali und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar. Hauptthemen laut MEDLINE: Ataxia Telangiectasia Mutated Proteins, Arsenites, Peroxiredoxins, DNA Damage. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
- Naaz Coker Ovarian Cancer Research Centre, Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
- Department of Pathology, Nottingham University Hospitals, City Hospital Campus, Nottingham NG5 1PB, UK.
- Department of Oncology, Nottingham University Hospitals, City Hospital Campus, Nottingham NG5 1PB, UK.
Zitieren
APA
Ali, R., Algethami, M., Sheha, A., Alqahtani, S., Altayyar, A., Lashen, A., Rakha, E., Sulaiman, A. A., Madhusudan, S., & Ramotar, D. (2025). PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling. Oncotarget. https://doi.org/10.18632/oncotarget.28720
Vancouver
Ali R, Algethami M, Sheha A, Alqahtani S, Altayyar A, Lashen A, et al. PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling. Oncotarget. 2025. doi:10.18632/oncotarget.28720
BibTeX
@article{Ali2025,
author = {Ali, Reem and Algethami, Mashael and Sheha, Amera and Alqahtani, Shatha and Altayyar, Ahmad and Lashen, Ayat and Rakha, Emad and Sulaiman, Abdallah Alhaj and Madhusudan, Srinivasan and Ramotar, Dindial},
title = {PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling},
journal = {Oncotarget},
year = {2025},
doi = {10.18632/oncotarget.28720}
}
EUVIMED